Honeywell introduces Manufacturing Excellence platform

1 min read

Honeywell has introduced its Manufacturing Excellence platform, a dashboard that provides real-time end-to-end production visualisation across the factory floor.

The solution digitiwes paper-based batch records, work instructions, and logbooks to ensure consistent compliance with standard operating procedures. Visibility of batch progress and alerts on critical process parameters enable users to respond quickly if batches start trending toward excursion beyond golden batch or expected limits, therefore saving batches and improving quality. Users in multiple roles achieve faster batch release by significantly reducing review process time, actions, and signatures. Batch history and reports support closed-loop continuous improvement.

The platform is compatible with SAP and other enterprise resource planning solutions and integrates seamlessly with Honeywell’s Sparta TrackWise quality management system, Experion distributed control systems and 3rd party systems at all levels of the manufacturing hierarchy. This provides unprecedented interoperability, transparency, and real-time insights to maximise production efficiency, quality, and compliance.

“This new platform will enable life sciences manufacturers to manage their production in one place. The platform can be deployed quickly and easily, in a modular approach, and more capabilities can be added as organizations advance on their journey”, said Shawn Opatka, VP and GM of Life Sciences at Honeywell Process Solutions.

The solution draws on Honeywell’s proven expertise in process control, SCADA, and batch historian technologies, as well as manufacturing execution systems to support life sciences manufacturers in their path to digitalisation. The Honeywell Manufacturing Excellence platform is built for life sciences pharmaceutical segments ranging from Active Pharmaceutical Ingredient (API) manufacturers and Contract Drug Manufacturing Operations (CDMO) to Biologics and Cell & Gene Therapy producers in various stages of product development, from clinical trials to commercialisation.

“With this integrated software solution, we continue to expand our capabilities and bring to market a solution that takes the industry forward, allowing for greater production speed, reliability and the highest levels of product quality and safety,” said Opatka.